{"schema_version":"secwatch.filing_event.v1","accession":"0002014596-25-000009","form_type":"8-K","ticker":"CON","cik":"0002014596","company_name":"Concentra Group Holdings Parent, Inc.","filed_at":"2025-03-03T23:59:59+00:00","discovered_at":"2026-05-14T18:03:05.802442+00:00","generated_at":"2026-05-25T21:53:41.537074+00:00","sec_items":["1.01","2.01","2.02","2.03","8.01","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Concentra Q4 revenue +5.5% to $465M, adjusted EBITDA +13.6%; closes $265M Nova acquisition; declares $0.0625 dividend","bullets":["Q4 revenue $465.0M (+5.5% YoY); net income $22.8M ($0.17 EPS).","FY2024 revenue $1,900.2M (+3.4% YoY); adjusted EBITDA $376.9M (+4.3% YoY).","Closed acquisition of Nova Medical Centers for $265M; adds 67 centers across 5 states.","2025 guidance: revenue ~$2.1B, adjusted EBITDA $410-425M; targeting net leverage ~3.0x in 18-24 months.","Declared quarterly dividend $0.0625/share, payable April 1 to March 18 record date."],"urls":{"canonical":"https://secwatch.observer/filing/0002014596-25-000009","json":"https://secwatch.observer/filing/0002014596-25-000009.json","markdown":"https://secwatch.observer/filing/0002014596-25-000009.md","text":"https://secwatch.observer/filing/0002014596-25-000009.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/2014596/000201459625000009/0002014596-25-000009-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/2014596/000201459625000009/cghp-20250301.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-25T21:53:41.537074+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"3e7d32fabec2efb321141cea440005e8c498b17c","claim":"Concentra Group Holdings Parent, Inc. completed an acquisition involving U.S. Occmed Holdings, LLC d/b/a Nova Medical Centers for $265 million (closed 2025-03-01).","evidence_excerpt":"Pursuant to the terms of the Purchase Agreement, CHS acquired all of the outstanding membership interests of Nova Medical Centers from the Sellers and paid a purchase price of $265 million, subject to certain customary adjustments in accordance with the terms set forth in the Purchase Agreement. CHS financed the transaction using a combination of cash on hand,","evidence_source":"SEC 8-K Item 2.01/5.01","evidence_url":"https://www.sec.gov/Archives/edgar/data/2014596/000201459625000009/0002014596-25-000009-index.htm","confidence":0.9,"family_label":"M&A Transactions","details":[{"label":"Action","value":"acquisition"},{"label":"Counterparty","value":"U.S. Occmed Holdings, LLC d/b/a Nova Medical Centers"},{"label":"Consideration","value":"$265 million"},{"label":"Closing","value":"2025-03-01"}],"fact_type":"ma_transaction"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}